New progress in migraine drug treatment
10.3760/cma.j.cn113694-20190922-00589
- VernacularTitle:偏头痛药物治疗新进展
- Author:
Xuejia DONG
1
;
Mingfang JIANG
Author Information
1. 内蒙古医科大学研究生院，呼和浩特 010058
- From:
Chinese Journal of Neurology
2020;53(5):385-390
- CountryChina
- Language:Chinese
-
Abstract:
Migraine is a recurrent chronic nervous system disease, the pathogenesis of which has not yet been fully clear. The disease has high incidence, recurrence and disability, seriously affecting the quality of life of patients, and bringing serious economic burden to society. At present, domestic specific therapeutic drugs are scarce and have serious side effects, which make the clinical treatment effect very limited. In recent years, with the further research on migraine, specific drugs for migraine treatment have been found, which bring more choices for the treatment of acute attack of migraine. At the same time, it also brings more hope to the preventive treatment of migraine. This article summarizes a large number of clinical trials on the treatment of migraine drugs by reviewing relevant literatures at home and abroad, systematically evaluates the safety, effectiveness and tolerance of these drugs in migraine treatment, and provides more help for migraine drug treatment research.
